Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.59 USD
Change Today +0.0399 / 7.25%
Volume 19.9K
PURE On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

pure bioscience inc (PURE) Snapshot

Open
$0.55
Previous Close
$0.55
Day High
$0.59
Day Low
$0.53
52 Week High
04/21/14 - $1.25
52 Week Low
11/10/14 - $0.48
Market Cap
24.1M
Average Volume 10 Days
37.2K
EPS TTM
$-0.23
Shares Outstanding
40.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PURE BIOSCIENCE INC (PURE)

Related News

No related news articles were found.

pure bioscience inc (PURE) Related Businessweek News

No Related Businessweek News Found

pure bioscience inc (PURE) Details

Pure Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States. It manufactures and distributes silver dihydrogen citrate based disinfecting and sanitizing products. The company’s technology platform is based on an electrochemical process that allows generating ionized silver in the presence of organic acid. It provides PURE Hard Surface, a hard surface disinfectant and food contact surface sanitizer for use in food processing equipment, machinery, and utensils; PURE Multi-Purpose Cleaner, an environmentally cleaning product for use in various resilient surfaces, such as floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate, an environmentally high foam forming cleaning product for use in stainless steel equipment, resilient floors, walls, and painted surfaces. The company also offers Axen 30, a hard surface disinfectant; Axenohl, an antimicrobial formulation used as a raw material in the manufacturing of environmental protection agency-registered products; and Silvérion, an antimicrobial formulation used as a raw material in the manufacturing of personal care products. Pure Bioscience, Inc. markets and sells its products primarily to distributors and end users. The company was formerly known as Pure Bioscience and changed its name to Pure Bioscience, Inc. in March 2011. Pure Bioscience, Inc. was founded in 1992 and is based in El Cajon, California.

12 Employees
Last Reported Date: 01/12/15
Founded in 1992

pure bioscience inc (PURE) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $406.5K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $397.5K
Compensation as of Fiscal Year 2014.

pure bioscience inc (PURE) Key Developments

PURE Bioscience, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015

PURE Bioscience, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015 . Venue: Caesars Palace, Las Vegas, Nevada, United States.

PURE Bioscience, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended January 31, 2015

PURE Bioscience, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended January 31, 2015. For the six months, the company announced net product sales of $390,000 compared to $156,000 for the same period a year ago. Loss from operations was $3,666,000 compared to $7,053,000 for the same period a year ago. Net loss was $3,670,000 compared to $6,326,000 for the same period a year ago. Basic and diluted net loss per share was $0.10 compared to $0.28 for the same period a year ago. Net loss, as adjusted for significant items was $2,685,000 compared to $2,570,000 for the same period a year ago. The company reported a quarter-end cash position of $3.9 million as of January 31, which reflects a sequential quarter-over-quarter reduction as the company’s use of operating cash for the fiscal second quarter 2015 of $1.3 million, as compared with the fiscal first quarter 2015 use of operating cash of $2.2 million, reflects a reduction of $900,000. For the quarter, the company announced net product sales of $273,000 compared to $41,000 for the same period a year ago. Loss from operations was $1,736,000 compared to $3,221,000 for the same period a year ago. Net loss was $1,736,000 compared to $2,482,000 for the same period a year ago. Basic and diluted net loss per share was $0.04 compared to $0.10 for the same period a year ago. Net loss, as adjusted for significant items was $1,254,000 compared to $1,499,000 for the same period a year ago.

PURE Bioscience, Inc., Q2 2015 Earnings Call, Mar 04, 2015

PURE Bioscience, Inc., Q2 2015 Earnings Call, Mar 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PURE:US $0.59 USD +0.0399

PURE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PURE.
View Industry Companies
 

Industry Analysis

PURE

Industry Average

Valuation PURE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 28.0x
Price/Book 4.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PURE BIOSCIENCE INC, please visit www.purebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.